“NH001–Cognitive Recovery After Severe Brain Injury”

In Clinical Development, Featured on App, Orphan Drug Congress by Freya SmaleLeave a Comment

Neal Farber of NeuroHealing Pharmaceuticals  joined us for World Orphan Drug Congress USA 2014 to present about ‘ NH001–Cognitive Recovery After Severe Brain Injury’ .
Download his presentation now  to learn about:

  • Medical rationale for use of dopaminergics for recovering consciousness in TBI
  • Rationale for use of NH001
  • NH001-1 Pilot Study Results
  • NH001-2 Study Design
…and much more!
Get your copy here!
To find out more about how  NH001 can provide cognitive recovery after severe brain injury , attend  World Orphan Drug Congress USA 2016 April 20-22  in Washington, DC.

Leave a Comment